Check-Points

About Check-Points

Check-Points
Check-Points is a privately owned diagnostics company founded in 2002 based in Wageningen, The Netherlands.
Check-Points

We focus on the development and commercialization of a new generation of molecular diagnostic solutions for specific routine applications in clinics, institutes and companies.

Check-MDR

The Check-MDR range is dedicated to improving the identification of multidrug resistance in Gram-negative bacteria, to support you in identifying and controlling the spread of ESBL, AmpC and carbapenemases.

Check-Points is the first to introduce a range of rapid molecular assays for the detection of Gram-negative antibiotic resistance with excellent sensitivity and specificity for carbapenemases, AmpC and ESBL. Rapid and accurate confirmation of antibiotic resistance is crucial for optimal patient treatment and infection control.

Our rapid molecular assays include microarray-based solutions that pinpoint the presence of multidrug resistance genes through simultaneous analysis of up to 100 resistance markers, as well as real-time assays, for quick confirmation of the ESBL or carbapenemase mechanism.

Check&Trace

Check&Trace Salmonella (previously Premi®Test Salmonella) is the first product in our new Check&Trace range for food and veterinary diagnostics. The Check&Trace Salmonella allows for fast and reliable routine molecular confirmation and serotyping of Salmonella. Serotyping of Salmonella has proven to be essential in any Salmonella reduction program.

Recent News

Newsletter

Sign up and stay informed about news